Leen Kawas on America's Pharmaceutical Manufacturing Renaissance: National Security Through Reshoring

Leen Kawas, a leading biotech professional, highlights ways in which the return of US manufacturing can be beneficial to the economy, the industry, and the overall wellness of individuals.

The United States is witnessing a significant shift in its pharmaceutical manufacturing landscape as companies increasingly move production operations back home after decades of offshoring. This reshoring movement, accelerated by recent global events and policy changes, represents a critical turning point for American healthcare security and economic resilience. According to biotechnology leader Leen Kawas, this trend marks an essential step toward strengthening the nation’s healthcare infrastructure.

Read Full Article Here